Myomo (NYSE:MYO) announced today that it launched its MyoCare program for providing support to first-year users of its MyoPro powered brace.
MyoCare offers expanded support to current and future clients who receive their MyoPro directly from the Cambridge, Mass.-based company, at no additional cost. Anyone who obtained the MyoPro from an authorized orthotics & prosthetics clinic will receive support from the clinic, according to a news release.
MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to weakened or paralyzed arms in people suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury.
The company touts MyoPro as the only marketed device that currently senses a patient’s own EMG signals through non-invasive sensors on the arm to restore the ability to perform daily activities.
“We have so many satisfied clients because of the quality and the utility of MyoPro,” Myomo CEO Paul Gudonis said in the release. “With MyoCare, we have a new program to ensure that those who may not have fully learned how best to restore function with the MyoPro can enhance their ability to perform critical activities of daily living, such as cooking, feeding themselves and carrying household objects, thus improving their quality of life. In addition, this initiative provides added benefit to clients who take advantage of our efficient direct billing channel.”
